Great Lakes Advisors, LLC Sage Therapeutics, Inc. Transaction History

Great Lakes Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$70.65 - $96.76 $14.7 Million - $20.1 Million	-207,692 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$58.41 - $89.06 $12.1 Million - $18.5 Million	207,692 New	207,692 $18 Million
Q4 2017 Feb 08, 2018	SELL	$60.72 - $167.34 $233,954 - $644,761	-3,853 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$61.4 - $88.52 $236,574 - $341,067	3,853	3,853 $240,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.